NEWS

AUA 2018: Selection of Appropriate Genitourinary Cancers for Immunotherapy – UroToday

AUA 2018: Selection of Appropriate Genitourinary Cancers for ImmunotherapyUroTodayHe highlighted FDA approved indications for immunotherapy in genitourinary oncology, including for urothelial carcinoma and clear cell renal cell carcinoma. Additionally,… Continue reading

Gene therapy that reverses blindness in dogs could also help treat humans – News-Medical.net

News-Medical.netGene therapy that reverses blindness in dogs could also help treat humansNews-Medical.netA Michigan State University veterinary ophthalmologist has modified a gene therapy that reverses blindness in dogs that have a certain form of a di… Continue reading

3 Things In Biotech, May 19: Buy BMY? Oncolytics In Again? Atara’s Immunotherapy Data – Seeking Alpha

Seeking Alpha

3 Things In Biotech, May 19: Buy BMY? Oncolytics In Again? Atara’s Immunotherapy Data Seeking Alpha Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication. Try for free today and see what we’re talking about! Here is some more information if you’re curious. Welcome to another edition of “3 Things In … and more »